AU4356299A - Utilization of growth factors for the production of medicaments - Google Patents

Utilization of growth factors for the production of medicaments

Info

Publication number
AU4356299A
AU4356299A AU43562/99A AU4356299A AU4356299A AU 4356299 A AU4356299 A AU 4356299A AU 43562/99 A AU43562/99 A AU 43562/99A AU 4356299 A AU4356299 A AU 4356299A AU 4356299 A AU4356299 A AU 4356299A
Authority
AU
Australia
Prior art keywords
medicaments
utilization
production
growth factors
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43562/99A
Inventor
Clarence Feldmann
Oscar E Illi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
White Spot AG
Original Assignee
White Spot AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by White Spot AG filed Critical White Spot AG
Publication of AU4356299A publication Critical patent/AU4356299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
AU43562/99A 1998-06-29 1999-06-29 Utilization of growth factors for the production of medicaments Abandoned AU4356299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1375/98 1998-06-29
CH137598 1998-06-29
PCT/CH1999/000278 WO2000000180A1 (en) 1998-06-29 1999-06-29 Utilization of growth factors for the production of medicaments

Publications (1)

Publication Number Publication Date
AU4356299A true AU4356299A (en) 2000-01-17

Family

ID=4208961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43562/99A Abandoned AU4356299A (en) 1998-06-29 1999-06-29 Utilization of growth factors for the production of medicaments

Country Status (4)

Country Link
EP (1) EP1091730A1 (en)
JP (1) JP2002519317A (en)
AU (1) AU4356299A (en)
WO (1) WO2000000180A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058426A1 (en) * 2000-02-09 2001-08-16 White Spot Ag Sustained release composition comprising insuline like growth factor
KR100720052B1 (en) 2005-10-07 2007-05-18 (주) 차바이오텍 Microsphere or microbead coated with nanoparticle containing growth factor for regenerating cartilaginous tissue
JP4843797B2 (en) * 2006-01-18 2011-12-21 国立大学法人 東京医科歯科大学 Biomaterial for bone formation containing osteogenesis promoting substance and nanogel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE252894T1 (en) * 1995-01-05 2003-11-15 Univ Michigan SURFACE-MODIFIED NANOPARTICLES AND METHODS FOR THEIR PRODUCTION AND USE
KR100236771B1 (en) * 1997-04-01 2000-02-01 성재갑 Hyaluronate microparticles for sustained release of drug
US6214008B1 (en) * 1997-04-16 2001-04-10 White Spot Ag Biodegradable osteosynthesis implant
EP0896825B1 (en) * 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors

Also Published As

Publication number Publication date
JP2002519317A (en) 2002-07-02
WO2000000180A1 (en) 2000-01-06
EP1091730A1 (en) 2001-04-18

Similar Documents

Publication Publication Date Title
AU4925799A (en) Production of propylene
AU3219000A (en) Controlling production
AU1430699A (en) Production of propylene
AU7653400A (en) Polyolefin production
AU3994299A (en) Process for preparing 4-aminodiphenylamines
AU7466900A (en) A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2
AU2484099A (en) Reactive distillation process for the production of xylenes
AU2748799A (en) Process for the production of a shaped article
AU4288900A (en) Production of polyethylene
AU2682200A (en) Process for the production of olefins
AU4902699A (en) Polyolefin production
AU1434301A (en) Process for the preparation of sulfamides
AU4267099A (en) Production of polyethylene
AU4659199A (en) Process for the preparation of urea
AU3330699A (en) Process for the production of microcapsules
AU4774099A (en) Polyolefin production
AU8627798A (en) Biocatalytic process for the preparation of 3-0-acyl-flavonoids
AU4356299A (en) Utilization of growth factors for the production of medicaments
AU7773700A (en) Method for the production or preparation of 2,6-dichlorotoluol
AU2566100A (en) Process for the production of a nutritional composition
AU4137799A (en) Polyolefin production
AU7306100A (en) A stereoselective process for the preparation of endo-3-aminoazabicycloalkanes
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU4010000A (en) Epimerization reaction for the production of r-fluoxetine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase